October 26, 2009
To make lasting change, you must first win the hearts and minds of the people on the shop floor.
 |
October 1, 2009
By:Gary Walsh, PhD
Ten biopharmaceuticals gained marketing authorization in the US or EU in 2008, although only four were new approvals.
|
October 1, 2009
By:Brandon J. Patterson
Automated in-line dilution can help solve capacity, financial, and quality concerns that biopharmaceutical manufacturing plants may be facing.
|
October 1, 2009
By:G. Steven Burrill
Biotech impressed investors with positive drug data, strong drug sales and earnings, and partnering deals.
|
October 1, 2009
By:Cindy Lieberman
Small changes can have a big effect further downstream in your manufacturing processes.
|
September 18, 2009
To assess current trends in laboratory equipment, BioPharm International turned to Francis Bach, North American sales director, Asahi Kasei TechniKrom, Inc.; Erika Lapinskas, PhD, product manager, Sartorius Stedim Biotech; Jeffrey R. Mazzeo, PhD, biopharmaceutical business director, Waters Corporation; Amber Ratcliff, product manager, analytical sensors, Hamilton Company; and Josh Silverstone, marketing director, Millipore Corp.
|
September 18, 2009
To assess current trends in information technology, automation, and process control, BioPharm International turned to Rick E. Cooley, market development manager?process analytics, Dionex Corporation, and James Erickson, president and chief executive officer, Blue Mountain Quality Resources, Inc.
|
| 
